A randomized, double-blind, placebo controlled multiple dose study of subcutaneous ACZ885 for the treatment of abdominal aortic aneurysm

Trial Profile

A randomized, double-blind, placebo controlled multiple dose study of subcutaneous ACZ885 for the treatment of abdominal aortic aneurysm

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Canakinumab (Primary)
  • Indications Abdominal aortic aneurysm
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 29 Jul 2016 This trial has been completed in Denmark (end date:2015-10-21) as per European Clinical Trials Database Record.
    • 13 Jan 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 22 Sep 2014 Planned End Date changed from 1 Aug 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top